SarcopeniaCritical IllnessIntensive Care (ICU) MyopathyBody Composition MeasurementBio-Impedance MeasurementsUltrasound Evaluation
Study summary
This is a prospective, observational study at the ICU of Hospital Mútua de Terrassa, running from May to December 2025. The primary goal is to determine the prevalence of sarcopenia in adult patients requiring more than 48 hours of mechanical ventilation. Sarcopenia is assessed using the SARC-F score, impedanciometry, and quadriceps ultrasound. Secondary aims include tracking the development of ICU-Acquired Weakness (ICU-AW) using the MRC score. All data is collected anonymously after obtaining informed consent.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Older than 18 years old.
* Expected duration of mechanical ventilation (MV) exceeding 48 hours.
Exclusion Criteria:
* Refusal to participate.
* Mechanical ventilation not exceeding 48 hours.
* Do-not-resuscitate (DNR) orders or limitations of therapeutic effort upon admission.
Primary outcome measure(s)
Prevalence of sarcopenia at the time of ICU admission. — Baseline at admission to ICU Describe the prevalence of sarcopenia at the time of ICU admission in patients with an expected duration of mechanical ventilation (MV) exceeding 48 hours.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
